Breast Cancer Clinical Trials in Georgia

Showing 261-280 of 335 trials

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

NCT02670577

The scope of this study is to measure the impact of MammaPrint on treatment in Hormone Receptor (HR)-positive HER2-negative breast cancer patients. In addition, the impact of MammaPrint on treatment in patients with T1a/T1b and pN0/pN1 (up to 1 node), Triple Negative or HER2-positive tumors will be assessed.

Breast Cancer

Agendia481 participantsStarted Nov 2015

Palm Springs, California, United States • Miami, Florida, United States • Tampa, Florida, United States +14 more locations

TERMINATEDPHASE265 miles

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

NCT00832338

The purpose of this study is to assess if docetaxel and cytoxan can shrink the size of your breast tumor and allow you to preserve your breast or have less extensive surgery on your breast. Additionally, by receiving chemotherapy before surgery, the investigators will be able to determine if your cancer is responsive to chemotherapy.

Breast NeoplasmsBreast CancerCancer of the Breast

Emory University23 participantsStarted Apr 2009

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores

Breast Cancer Trials in Other Cities

Digital Mammography Screening Trial (ACRIN6652)

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

NOLAN: Naproxen or Loratadine and Neulasta

Ixabepilone + Carboplatin Metastatic Breast Cancer

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

Irinotecan and Docetaxel in Treating Patients With Refractory Metastatic Breast Cancer

LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

Docetaxel and Carboplatin in Treating Women With Metastatic Breast Cancer

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

Other Conditions in Georgia